Evidence map›Paper›PMID 42819902›Full record

ArticleOpen forum infectious diseases2026

Inflammation Precedes Paradoxical Reactions in HIV-Negative Patients With Pulmonary Tuberculosis.

Lisa Kurver, Eefje Klein Teeselink, Simon E Koele, Nicolien Hanemaaijer, Arthur Lemson, Cedric Bosteels, Neeltje Carpaij, Edwin Ardiansyah, Rianne Vullinghs, Cécile Magis-Escurra and 11 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lisa KurverDepartment of Internal Medicine, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0001-7731-9827
Eefje Klein TeeselinkDepartment of Internal Medicine, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Simon E KoeleDepartment of Pharmacy, Pharmacology and Toxicology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Nicolien HanemaaijerDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Arthur LemsonDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0009-0007-8688-1812
Cedric BosteelsDepartment of Respiratory Medicine, European Reference Network on Rare Respiratory Diseases (ERN-LUNG), Ghent University Hospital, Ghent, Belgium.
Neeltje CarpaijDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Edwin ArdiansyahResearch Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, Indonesia.ORCID https://orcid.org/0000-0003-2702-5497
Rianne VullinghsDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Cécile Magis-EscurraDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Ingrid J M van WeerdenburgDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Bram GeurtsDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-1960-4491
Steven SchalekampDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.
Alfons A den BroederDepartment of Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Lindsey Te BrakeDepartment of Pharmacy, Pharmacology and Toxicology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Rob J W ArtsDepartment of Internal Medicine, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Jakko van IngenDepartment of Medical Microbiology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-0581-2003
Wouter HoefslootDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Rob AarnoutseDepartment of Pharmacy, Pharmacology and Toxicology, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
Cynthia van ArkelDepartment of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-0995-018X
Arjan van LaarhovenDepartment of Internal Medicine, Radboudumc Community for Infectious Diseases, and Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID https://orcid.org/0000-0002-6607-4075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: "Paradoxical reactions" are a poorly understood phenomenon of clinical worsening during adequate antibiotic tuberculosis treatment. We aimed to characterize and predict paradoxical reactions using clinical, microbiological, and inflammatory factors in human immunodeficiency virus (HIV)-negative patients with pulmonary tuberculosis. Methods: We closely monitored HIV-negative patients aged ≥16 years who were admitted to a Dutch referral center. Paradoxical reactions were defined as new or increased tachypnea with hypoxemia or new or increased need for supplemental oxygen, after exclusion of alternative causes. Blood inflammatory parameters at onset of paradoxical reaction, and 1 and 2 weeks prior were matched for treatment duration to those of patients without paradoxical reactions and compared using Stouffer Results: Among 81 HIV-negative patients with pulmonary tuberculosis, 19 (24%) experienced a paradoxical reaction, after a median of 13 days of antituberculosis treatment (interquartile range, 8-18 days). Paradoxical reactions were characterized by higher C-reactive protein level (Stouffer Conclusions: Paradoxical reactions in HIV-negative individuals with pulmonary tuberculosis concur with, and are preceded by, outspoken systemic inflammation. Baseline inflammatory parameters may guide future stratified preemptive immunomodulation.

Indexed as

anergyinflammationmycobacterial loadparadoxical reactiontuberculosis

Identifiers

PMID42819902
PMCPMC13625187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.